key: cord-0912289-m5iecgd9
authors: Johansson, Jan; Levi, Richard; Jakobsson, Maria; Gunnarsson, Stina; Samuelsson, Kersti
title: Multi-professional Neurorehabilitation after Covid-19 Infection Should Include Assessment of Visual Function: Visual function after Covid-19 infection
date: 2022-01-31
journal: Arch Rehabil Res Clin Transl
DOI: 10.1016/j.arrct.2022.100184
sha: ee71668fdfc3a73c28b07d35072b9bf1f4c8da4f
doc_id: 912289
cord_uid: m5iecgd9

OBJECTIVE: To report vision-related symptoms and neuro-visual clinical signs in patients approximately 4 months after discharge from hospitalization after Covid-19 infection. To report on co-existing functional and activity limitations. DESIGN: The study is part of an ambi-directional population-based cohort study. SETTING: An outpatient setting in a hospital environment. PARTICIPANTS: Patients from a population-based cohort study including all laboratory-confirmed cases of Covid-19 admitted to hospital during a 3-month period in a health care region in Sweden. Among patients who, based on a standardized telephone interview, were identified as having persisting rehabilitation needs 4 months after discharge (n=185), several (n=57) reported vision-related symptoms. All 57 patients were invited to a neuro-visual examination. Six patients declined, six were unavailable and three did not fulfil the inclusion criteria. Thus 42 patients were included in the analysis. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Vision-related symptoms, neuro-visual function, and co-existing impairments affecting activities of daily life and participation. RESULTS: Thirty-one percent of patients with rehabilitation needs after Covid-19 reported vision-related symptoms. Reading-related issues (73.8%), blurry vision (69.0%), and light sensitivity (66.7%) were the most common symptoms. Patients with reading-related issues showed a higher level of eye strain (p<0.001). Neuro-visual deficits were found in 83.3% of the patients, mainly concerning eye teaming (23.1%–66.7%) and eye movement (28.6%–30.8%) functions. Patients with vision-related symptoms reported fatigue and 18 other co-existing symptoms to a greater extent (p≤0.0001 to 0.049). CONCLUSIONS: Neuro-visual symptoms and signs should be considered when assessing rehabilitation needs after Covid-19. The association between vision-related issues and co-existing symptoms with an impact on body function and activity/participation underlines the need for multi-professional rehabilitation assessment and intervention.

The World Health Organization (WHO) declared Covid-19 a pandemic in March 2020 and the virus has had, and likely will continue to have, a significant impact on the world's population as well as on health care and socio-economic structures. 1 The virus has been described as a multi-system disease affecting different organs and body functions, often with prolonged consequences on the health and daily life of individuals. 2, 3 The central and peripheral nervous system may be affected, leading to a wide variety of neurologic manifestations. 4, 5 Due to the heterogeneity of the manifestations, different possible pathogenic pathways have been suggested, e.g., direct neural invasion, immunemediated processes, endothelial dysfunction, and hypercoagulability. [6] [7] [8] The increasing number of studies reporting on a variety of symptoms persisting after Covid-19, particularly cognitive impairments, underscore the need for multi-professional rehabilitation. [3] [4] [5] [9] [10] [11] One commonly reported symptom that persists after Covid-19 is mental fatigue, often in combination with neuro-cognitive symptoms such as memory impairment, concentration difficulties, and/or an increased sensitivity to light and sound, all of which have an impact on a person's ability to manage their daily life. 12 However, symptoms related to visual dysfunction have rarely been examined and described in this context. Issues pertaining to visual function [13] [14] [15] and its combination with mental fatigue 16, 17 have been described in patients with acquired brain injuries (ABIs). By analogy, visual function should potentially be considered in the review of patients' rehabilitation needs after Covid-19. In addition, visual impairments have been found to affect the ability to benefit from rehabilitation and resume daily activities after ABI. [18] [19] [20] [21] Ophthalmic (eye-related) manifestations associated with Covid-19 may occur as a presenting feature of the disease or may develop weeks after recovery. 22 The prevalence is reported to be low, 23, 24 and they most commonly involve the anterior part of the eye, e.g., dry eyes and conjunctivitis. 23, 25, 26 In addition, inner parts of the eye may be involved, e.g., retinal disease. 8, 22 Neuro-ophthalmic symptoms include headache, ocular pain, visual impairment, and double vision, 24 and the signs may involve optic neuritis, visual disturbances due to encephalopathy or stroke, cranial nerve palsies, and eye movement disorders. 8 In addition to healthy eyes, different neuro-visual skills are required for functional vision and performance of daily activities. In this context, we refer to the ability to comfortably maintain clear, stable, and flexible vision in daily activities, occupational tasks, and interaction with others. Basic visual functions enabling this include visual acuity, contrast vision, binocular (eye teaming) functions, and eye movements.

This study reports on persisting neuro-visual function issues and symptoms after discharge from hospitalization due to Covid-19 infection. A second aim was to report on coexisting functional and activity limitations as sequelae of the infection.

This study is part of the Linköping Covid-19 (LinCoS) Study, an ambi-directional population-based cohort study that included all laboratory-confirmed cases of Covid-19 admitted to hospital during a 3-month period in one of 21 health care regions in Sweden. All survivors at 4 months after discharge (n=460) were invited to participate in a structured telephone interview. A total of 433 patients participated (response rate 94%). 3 As part of the LinCoS-study, medical records were searched to classify the severity of Covid-19 at hospitalization according to the WHO Clinical Progression Scale (CPS). 3 Patients were classified as follows: CPS 4-5, hospitalized, moderate disease; CPS 6, hospitalized, severe disease, non-mechanically ventilated; and CPS 7-9, hospitalized severe disease.

The interview followed a standardized protocol comprising 37 questions, including questions on persisting symptoms from Covid-19 on body function (n=25) as well as activity/participation (n=12), referring to the International Classification of Function, Disability and Health. 27 Patients were instructed to only report new or exacerbated symptoms in relation to Covid-19. For each reported symptom, the patient was asked to estimate the impact on everyday life on a scale from 1 to 5 (1, no impact; 2, to a minor degree; 3, to some degree; 4, to a high degree; 5, to a very high degree). Eight questions concerned vision-related symptoms (shown in table 1) and were selected based on symptoms commonly found in individuals undergoing rehabilitation due to ABI or disease. 14,28

About 40% of all interviewed patients were identified by the interviewers and confirmed with a rehabilitation team as having a need for further clinical assessments and potentially rehabilitation interventions, based primarily on to what degree the symptoms affected daily life. Those participants were then invited to a clinical examination by a multiprofessional rehabilitation team about 5 months after discharge from hospital ( fig 1) . Patients who reported neuro-visual symptoms with a significant impact on daily life (3-5 on the rating scale) at the time of the interview or at the clinical visit were offered a special neuro-visual assessment approximately 5-6 months after hospitalization. Non-Swedish-speaking patients were assisted by an interpreter both at the telephone interview and the neuro-visual examination.

The neuro-visual examination included a detailed self-reported assessment of visionrelated symptoms, an in-depth vision examination, and an assessment of reading-related oculomotor skills.

Vision-related self-reported symptoms were assessed with the Vision Interview (VI) 28 and the Convergence Insufficiency Symptom Survey (CISS). 29 These documents were filled in by the patient before the vision examination. The VI is an 18-item structured questionnaire (questions shown in table 2) intended as support when reviewing visual impairments after ABI, including infection diagnoses. CISS consists of 15 questions concerning symptoms associated with reading and near activity graded on a Likert scale (0, never; 1, infrequently; 2, sometimes; 3, fairly often; 4, always). A total score of 21 or more is considered a high level of symptoms. 30 Symptoms concerning light sensitivity and dizziness were assessed as part of the anamnesis using a selection of questions adapted from questionnaires in previous research. 31, 32 The in-depth vision examination was performed by a licensed optometrist with neurorehabilitation experience. It included a brief anamnesis, visual acuity at near and far, eye motility, stereovision, eye teaming function, eye movement function, accommodation, and contrast vision (table 3) . Eye motility and eye movement function were clinically examined using criteria adapted from the Ocular Motor Score . 33 Exclusion criteria were premorbid eye disease and neurologic disorder causing severe visual impairment.

The Developmental Eye Movement Test 34 was used to examine oculomotor skills in a simulated reading task. The patient reads out numbers arranged vertically and horizontally on three different test cards. The ratio between vertical and horizontal reading duration is then calculated.

The statistical analyses were done using IBM SPSS Statistics 25 (IBM, Armonk, NY) and/or Microsoft Excel 2010 (Microsoft, Seattle, WA). Chi-squared or Fisher's exact test was used for analysis of cross-tabulations of frequencies. Welch's t test or ANOVA was used for comparing means. Normality tests were performed with the Kolmogorov-Smirnov method. A p value <0.05 was set as the level of significance.

The study adhered to the tenets of the Declaration of Helsinki and was approved by the Swedish Ethical Review Authority (Dnr 2020-03029 and 2020-04443). All patients gave informed consent before participation.

Fifty-seven of the 185 patients invited to a clinical examination (31%) were also invited to a neuro-visual examination. A total of 42 patients attended the examination and were thus included in the analysis (table 4).

The validity of the selection process of patients invited to a neuro-visual assessment was reviewed retrospectively; the responses from those invited (n=57) were compared to those not invited (n=128) for six of the eight telephone interview questions about visual symptoms (questions about headache and giddiness excluded). A chi-squared test showed a significant association between group and symptoms, confirming that patients invited to the vision examination were much more likely to experience visual symptoms affecting their daily life (p<0.01).

The number of patients who responded affirmatively to questions pertaining to visual dysfunction and rated the impact 3 to 5 (certain to high impact on daily life) are shown in table 1. A chi-squared test showed no association between symptoms and CPS classification.

The most reported symptoms were reading difficulties, blurry vision, dazzled by light, and an increased need for light while reading (table 2) . Patients who had experienced a visual phenomenon described it as foggy vision (n=15) or in the form of flares, dots of light, or stars in their field of vision (n=13).

The mean CISS score was 25.9 (standard deviation [SD], 10.6) for the total group, suggesting an increased level of symptoms (cut-off score ≥21). There was no difference between the groups based on CPS classification. For patients experiencing reading-related difficulties according to VI (n=31), the mean CISS score was 29.7 (SD, 8.8) compared to 15.2 (SD, 7.3) for patients without reading-related difficulties (p<0.01).

In the anamnesis, 20 patients reported headaches of greater intensity or to occur more frequently after the infection. Six patients reported the headache to be specifically associated with reading and near activity according to CISS.

Twenty-three patients (54.8%) experienced moderate to severe discomfort when exposed to light and that vision was degraded when exposed to light. Common factors perceived to worsen the symptoms were fatigue, time (worsens as the day goes on), watching television, and the use of a computer, tablet, or mobile phone. All types of light, indoors as well as outdoors, could be bothersome. No association between symptoms and the CPS classification was found. There was no association between light sensitivity and headache.

Twenty-eight patients (66.7%) graded symptoms of dizziness as always present. Four patients reported that symptoms were associated with head movement and ten patients reported motion in the environment as the cause of symptoms. The remaining 14 patients reported that symptoms were associated with both conditions. Table 5 describes the symptoms at group level. A chi-squared test of independence showed no association between symptoms and CPS classification.

Before the neuro-visual examination, each patient was asked to grade their present level of fatigue using a Numeric Rating Scale (NRS), where 0 = no fatigue and 10 = extreme fatigue. This was performed to get an estimate of self-perceived fatigue on the examination day. Thirty-four patients provided a rating, resulting in a mean score of 4.8 (SD, 2.8).

Thirty-five patients (83.3%) had one or more clinical signs concerning eye teaming function, accommodative function, eye movements, or reacted to motion in the peripheral field (table 6) . No associations between symptoms and CPS classification were found. The types of clinical signs are specified in table 7.

All patients performed the Developmental Eye Movement Test. Two patients were outliers (exceeded 3rd quartile + 1.5 × interquartile range) and thus excluded. There was no difference in the parameters or the ratio between patients who experienced reading issues according to the VI and patients who did not. There was no difference in the results between patients who had increased symptoms according to CISS (>21) and those who did not. A oneway ANOVA showed no difference in the ratio based on the CPS classification.

A chi-squared test for independence was performed to explore associations between symptoms according to the VI and clinical signs found in the vision examination. For reading difficulties (VI question 3), there was an association with a deficit in vestibular ocular reflex (VOR) head movement (Fisher's exact test, p=0.02). For other visual concern (VI question 16) , there was an association with eye movement deficits (Fisher's exact test, p=0.04) and VOR head movement (Fisher's exact test, p<0.01). Other vision concern included blurry or foggy vision, fluttery vision, a delay in visual perception, sore eyes, watching television feels different, and impaired depth perception.

Twenty-eight patients reported always experiencing at least one symptom related to dizziness, due to head movement, motion in the environment, or a combination. In patients who had symptoms of dizziness associated with head movement, a chi-squared test for independence showed associations with deficit in VOR head movement (p=0.01) and deficit in eye teaming width at distance (p=0.02). No associations were found between clinical signs and dizziness associated with motion in the environment. 

The results are based on telephone interview data from patients who had a clinical team examination (n=128) versus those who also had a vision examination (n=42). The results demonstrate a difference in the distribution of symptom prevalence between the groups.

Patients invited to the vision examination did report symptoms affecting their daily life to a greater extent (table 8).

Of the 433 patients interviewed 4 months after discharge from hospital, 13.9% were identified as experiencing a significant impact from at least one of the symptoms considered to indicate a neuro-visual dysfunction. Headache was reported by 47%. In patients who reported that headaches were associated with reading or near activity, obvious neuro-visual deficits and/or suboptimal correction were found. Thus, it appears that neuro-visual deficits may be part of the mechanism but given the overall constellation of symptoms, the mechanism is likely to be multi-factorial.

Twenty-three patients (55%) reported discomfort in the eye or head when exposed to light, indicating that they had light sensitivity (photophobia). 37 Common ocular conditions that may cause photophobia are dry eye or eye disease. Dry eye disease has been reported after Covid-19-infection. 25, 26 Four patients with symptoms of gritty and sore eyes, intermittent blurry vision, and light sensitivity that worsened when watching television or using a computer or mobile phone were referred for ophthalmologic assessment. Otherwise, there were no suspected signs of ocular disease in the vision examination or ocular history.

Migraine and other primary headaches are common neurologic disorders that may cause light sensitivity. 37, 38 The current analysis did not show any significant associations between headache and light sensitivity. However, high percentages of headache and light sensitivity have been reported in the acute phase 39 and as part of the long-term symptoms, 23,24,40 therefore further study may be warranted to explore the association.

About two thirds of the patients reported symptoms of dizziness. Dizziness is a neurologic manifestation associated with Covid-19 with a prevalence of 0.6%-21%. 6, 41 Reports describing the mechanism are scarce due to limited research involving complete vestibular evaluations. 42 A considerable percentage of the patients reported symptoms provoked by visual motion, suggesting visual vertigo (VV). VV is defined as dizziness provoked by visual environments with large size repetitive or moving visual patterns. 43 Patients typically experience dizziness and discomfort in situations such as busy crowded places, in traffic, or when walking down supermarket aisles. VV may be present in patients with a history of a peripheral vestibular disorder and especially in those with high visual dependence. 43 Eighty-three percent of the patients examined had clinical signs verified with objective assessment methods. This suggests that a fairly brief battery of questions can identify patients with a potential need for intervention.

The association between fatigue and visual functions may be a subject for further study. However, the difference in the frequency of reporting cognitive impairment affecting daily life in patients with visual impairment compared with those who did not is notable. In the present study, a significant difference in self-estimated fatigue was found between patients with three or more clinical signs and those with two or less. Similar findings have been presented for patients with ABI where an association between fatigue according to the Mental Fatigue Scale and visual symptoms has been shown. 16 Our findings suggest that visual symptoms after Covid-19 may be associated with objective visual function issues. In a clinical setting, some of these issues could be verified through visual screening or by referring to an optometrist or other eye care specialist.

Important basic interventions intended to support return to daily activities should be given in an individually adapted mix of, e.g., vision therapy, proper spectacle correction, customized spectacles for reading and near activity, tinted lenses and guidance on visual ergonomics.

The study was a cohort study and included all patients who were hospitalized due to Covid-19 infection in a health care region. All patients were interviewed according to a standardized protocol based on the International Classification of Function, Disability and Health and included vision-related items. The study also included those who spoke a foreign language (via an interpreter).

The final sample size (n=42) is fairly small and further research is required to verify the findings. The interview items regarding visual symptoms were chosen based on available knowledge at the time and some symptoms may therefore not have been captured. The selection of the study group was based on self-reported symptoms. For patients with other and more troublesome symptoms, vision-related symptoms might have been neglected and thus not reported. Patients invited for a neuro-visual assessment were younger and reported a higher level of mental fatigue than those who were not invited. Younger patients might be more affected by visual dysfunctions due to a higher expected level of activity than older patients. The vision examination did not include ophthalmologic examinations and therefore the study does not fully take ocular health into consideration. In those patients who declined participation, it is unclear if this was due to spontaneous recovery or other reasons.

Neuroimaging data were not included in this study and therefore the study does not take neurologic diagnoses into consideration. Finally, the study included only those who rated a certain level of impact or higher and therefore underreporting is possible.

We conclude that a considerable proportion of patients (31%) with potential 

When bending over? 5 21 16 When rolling over? 11 16 15 When turning your head quickly? Eighteen patients responded that they always experienced at least one of the symptoms in association with head movement, e.g., when changing posture or turning the head. Twenty-four patients responded that they always experienced at least one of the symptoms associated with motion in the environment. 

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 -11

Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review

Rehabilitation needs and mortality associated with the Covid-19 pandemic: a population-based study of all hospitalised and home-healthcare individuals in a Swedish healthcare region

Neurological manifestations in COVID-19 infection: a systematic review and meta-analysis

Neurological associations of SARS-CoV-2 infection: a systematic review

Epub ahead of print

Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians

The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries

Afferent and efferent neuro-ophthalmic complications of coronavirus disease 19

Post-acute COVID-19 syndrome

Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study

Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation

Fourmonth clinical status of a cohort of patients after hospitalization for COVID-19

How to assess visual function in acquired brain injury-Asking is not enough

Occurrence of oculomotor dysfunctions in acquired brain injury: a retrospective analysis

Visual impairment following stroke: do stroke patients require vision assessment?

Vision-related symptoms after acquired brain injury and the association with mental fatigue, anxiety and depression

An observational study of trait and state fatigue, and their relation to cognitive fatigability and saccade performance

Improving outcome in stroke patients with visual problems

Stroke survivors' views and experiences on impact of visual impairment

Participation and quality of life for persons with oculomotor impairments after acquired brain injury

COVID-19 and eye: a review of ophthalmic manifestations of COVID-19

An update on COVID-19 related ophthalmic manifestations

A review of neuro-ophthalmological manifestations of human coronavirus infection

Ocular findings among patients surviving COVID-19

Ocular surface impairment after coronavirus disease 2019: a cohort study

International Classification of Functioning, Disability and Health (ICF)

Visual dysfunction is underestimated in patients with acquired brain injury

Validity and reliability of the revised convergence insufficiency symptom survey in children aged 9 to 18 years

Validity and reliability of the revised convergence insufficiency symptom survey in adults

Critical flicker frequency and related symptoms in mild traumatic brain injury

Ocular fixation, vestibular dysfunction, and visual motion hypersensitivity

Ocular motor score a novel clinical approach to evaluating ocular motor function in children

Developmental Eye Movement Test, Examiners Booklet, Version 1

Reading Fluency-Current Insights from Neurocognitive Research and Intervention Studies

Rehabilitation after COVID-19: an evidence-based approach

Shedding light on photophobia

Photophobia: when light hurts, a review

Headache as a cardinal symptom of coronavirus disease 2019: a cross-sectional study

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms

SARS-CoV-2 (COVID-19) and audiovestibular disorders

Vision and vertigo: some visual aspects of vestibular disorders

Normal values for the Pelli-Robson contrast sensitivity test

Days in intensive care, median (min-max) 12 (8-31) (n=9) -(n=0) 10 (n=1)

ADL, activity of daily living; n.s., not significant. *Activity/participation

Acknowledgment of any presentation of this material: none